Securities code: Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) securities abbreviation: Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) Announcement No.: pro 2022030
Nan Jing Xin Jie Kou Department Store Co.Ltd(600682)
Announcement on the progress of the company’s asset replacement and related party transactions
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) (hereinafter referred to as the company or Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) ) disclosed the announcement of Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) on the company’s asset replacement and related party transactions (Announcement No.: pro 2022008) on April 7, 2022, Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) plans to carry out asset replacement with Nanjing sanbo medical management Co., Ltd. (hereinafter referred to as Nanjing sanbo medical), The company replaced the 100% equity of Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) Real Estate Development Co., Ltd. held by the company with the 80% equity of Xuzhou new health geriatric hospital Co., Ltd. held by Nanjing sanbo medical (hereinafter referred to as replacement matters). On the same day, the company received the inquiry letter on Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) asset replacement and related party transactions (shgh [2022] No. 0220) (hereinafter referred to as the inquiry letter) issued by the supervision department of listed companies of Shanghai Stock Exchange, and disclosed the announcement of delaying the reply to the inquiry letter on April 14, April 20, April 28 and May 10, 2022, For details, see the announcement information disclosed by the company (Announcement No.: pro 2022010, 011, 013, 014, 026).
At present, the reply contents of the company’s inquiry letter have been basically prepared. The replacement matters need to comply with the relevant review procedures of the financial and debt Commission of sancell group. At the same time, the company is still further communicating and clarifying with Nanjing sancell medical about the issues highly concerned by investors and some details of the replacement matters. In order to ensure the legal and compliant progress of the replacement, the company will timely disclose the reply to the inquiry letter and start the procedures of the general meeting of shareholders after the above matters are clarified. There is a risk that the transaction will be terminated due to the failure of the financial debt Committee of Sanxin group to pass the review, and the replacement still needs to be considered and approved by the general meeting of shareholders. Please invest rationally and pay attention to investment risks. The company will continue to maintain communication with all parties and timely perform the obligation of information disclosure in strict accordance with the requirements of relevant laws, regulations and normative documents.
The information disclosure media designated by the company are China Securities News, Shanghai Securities News, securities times and the website of Shanghai Stock Exchange (www.sse. Com. CN), Relevant information shall be subject to the announcement information disclosed by the company in the above designated media.
It is hereby announced.
Nan Jing Xin Jie Kou Department Store Co.Ltd(600682)
Securities code: Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) securities abbreviation: Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) Announcement No.: pro 2022030
Board of directors may 24, 2022
